BubR1A1204K.PR brains treated with colchicine exhibit a 2.5-fold increase in mitotic density, similar to wild-type. Premature sister chromatid separation rose sevenfold after 60 minutes in colchicine.
BubR1A1204K.PR, mad2G6595 has lethal | larval stage phenotype
BubR1A1204K.PR, mad2G6595 has lethal | pupal stage phenotype
BubR1A1204K.PR, mad2G6595 has abnormal mitotic cell cycle phenotype
BubR1A1204K.PR-mad2G6595 double mutants are not delayed in prometaphase (as in BubR1A1204K.PR single mutants) but instead show a rapid mitotic transit time and early onset of CycB degradation (as in mad2G6595 single mutants). Double mutants are uniformly larval/pupal lethal and double mutant brains exhibit a lower mitotic density with neuroblast aneuploidy and abnormal anaphases more frequent than in both single mutants.
BubR1A1204K.PR cnnHK21 double mutants exhibit low aneuploid rates as in the single mutants and survive to adulthood.